Effects ofGinkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age-associated cognitive impairment

This publication has 99 references indexed in Scilit:

• Regulation of APP cleavage by α‐, β‐ and γ‐secretases
  FEBS Letters, 2000
• Peripheral-type benzodiazepine receptors: Their implication in brain disease
  Drug Development Research, 2000
• Molecular interactions on microarrays
  Nature Genetics, 1999
• Increased peripheral benzodiazepine binding sites in the brain of patients with Huntington's disease
  Neuroscience Letters, 1998
• Increased Activity‐Regulating and Neuroprotective Efficacy of α‐Secretase‐Derived Secreted Amyloid Precursor Protein Conferred by a C‐Terminal Heparin‐Binding Domain
  Journal of Neurochemistry, 1996
• Gene-Representing cDNA Clusters Defined by Hybridization of 57,419 Clones from Infant Brain Libraries with Short Oligonucleotide Probes
  Genomics, 1996
• Excess EDRF/NO, a potentially deleterious condition that may be involved in accelerated atherogenesis and other chronic disease states
  General Pharmacology: The Vascular System, 1995
• Demonstration of the “anti-stress” activity of an extract of Ginkgo biloba (EGb 761) using a discrimination learning task
  General Pharmacology: The Vascular System, 1994
• The Nitric Oxide-Scavenging Properties of Ginkgo Biloba Extract EGb 761
  Biochemical and Biophysical Research Communications, 1994
• The physiology and mechanisms of the stress-induced changes in prolactin secretion in the rat
  Life Sciences, 1990